2023 ICD-10-CM Diagnosis Code Z79.84

Long term (current) use of oral hypoglycemic drugs

    2017 - New Code 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
  • Z79.84 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2023 edition of ICD-10-CM Z79.84 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of Z79.84 - other international versions of ICD-10 Z79.84 may differ.
Applicable To
  • Long term (current) use of oral antidiabetic drugs
Type 2 Excludes
Type 2 Excludes Help
A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code (Z79.84) and the excluded code together.
  • long-term (current) use of injectable non-insulin antidiabetic drugs (
    ICD-10-CM Diagnosis Code Z79.85

    Long-term (current) use of injectable non-insulin antidiabetic drugs

      2023 - New Code Billable/Specific Code POA Exempt
    Type 2 Excludes
    • long term (current) use of insulin (Z79.4)
    • long term (current) use of oral hypoglycemic drugs (Z79.84)
    Z79.85
    )
  • long term (current) use of insulin (
    ICD-10-CM Diagnosis Code Z79.4

    Long term (current) use of insulin

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    Type 2 Excludes
    • long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
    • long term (current) use of oral antidiabetic drugs (Z79.84)
    • long term (current) use of oral hypoglycemic drugs (Z79.84)
    Z79.4
    )
The following code(s) above Z79.84 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to Z79.84:
  • Z00-Z99
    2023 ICD-10-CM Range Z00-Z99

    Factors influencing health status and contact with health services

    Note
    • Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
    • (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
    • (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.
    Factors influencing health status and contact with health services
  • Z77-Z99
    2023 ICD-10-CM Range Z77-Z99

    Persons with potential health hazards related to family and personal history and certain conditions influencing health status

    Code Also
    • any follow-up examination (Z08-Z09)
    Persons with potential health hazards related to family and personal history and certain conditions influencing health status
  • Z79
    ICD-10-CM Diagnosis Code Z79

    Long term (current) drug therapy

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Code Also
    • any therapeutic drug level monitoring (Z51.81)
    Includes
    • long term (current) drug use for prophylactic purposes
    Type 2 Excludes
    • drug abuse and dependence (F11-F19)
    • drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)
    Long term (current) drug therapy
Present On Admission
POA Help
"Present On Admission" is defined as present at the time the order for inpatient admission occurs — conditions that develop during an outpatient encounter, including emergency department, observation, or outpatient surgery, are considered POA.
  • Z79.84 is considered exempt from POA reporting.
ICD-10-CM Z79.84 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
  • 949 Aftercare with cc/mcc
  • 950 Aftercare without cc/mcc

Convert Z79.84 to ICD-9-CM

Code History
  • 2017 (effective 10/1/2016): New code
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
Code annotations containing back-references to Z79.84:
  • Type 2 Excludes: Z79.4
    , Z79.4
    , Z79.85
    ICD-10-CM Diagnosis Code Z79.4

    Long term (current) use of insulin

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    Type 2 Excludes
    • long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
    • long term (current) use of oral antidiabetic drugs (Z79.84)
    • long term (current) use of oral hypoglycemic drugs (Z79.84)
    ICD-10-CM Diagnosis Code Z79.4

    Long term (current) use of insulin

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    Type 2 Excludes
    • long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
    • long term (current) use of oral antidiabetic drugs (Z79.84)
    • long term (current) use of oral hypoglycemic drugs (Z79.84)
    ICD-10-CM Diagnosis Code Z79.85

    Long-term (current) use of injectable non-insulin antidiabetic drugs

      2023 - New Code Billable/Specific Code POA Exempt
    Type 2 Excludes
    • long term (current) use of insulin (Z79.4)
    • long term (current) use of oral hypoglycemic drugs (Z79.84)
  • Use Additional: E08
    , E08
    , E11
    , E11
    , E13
    , E13
    ICD-10-CM Diagnosis Code E08

    Diabetes mellitus due to underlying condition

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Code First
    • the underlying condition, such as:
    • congenital rubella (P35.0)
    • Cushing's syndrome (E24.-)
    • cystic fibrosis (E84.-)
    • malignant neoplasm (C00-C96)
    • malnutrition (E40-E46)
    • pancreatitis and other diseases of the pancreas (K85-K86.-)
    Type 1 Excludes
    • drug or chemical induced diabetes mellitus (E09.-)
    • gestational diabetes (O24.4-)
    • neonatal diabetes mellitus (P70.2)
    • postpancreatectomy diabetes mellitus (E13.-)
    • postprocedural diabetes mellitus (E13.-)
    • secondary diabetes mellitus NEC (E13.-)
    • type 1 diabetes mellitus (E10.-)
    • type 2 diabetes mellitus (E11.-)
    Use Additional
    • code to identify control using:
    • insulin (Z79.4)
    • oral antidiabetic drugs (Z79.84)
    • oral hypoglycemic drugs (Z79.84)
    ICD-10-CM Diagnosis Code E08

    Diabetes mellitus due to underlying condition

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Code First
    • the underlying condition, such as:
    • congenital rubella (P35.0)
    • Cushing's syndrome (E24.-)
    • cystic fibrosis (E84.-)
    • malignant neoplasm (C00-C96)
    • malnutrition (E40-E46)
    • pancreatitis and other diseases of the pancreas (K85-K86.-)
    Type 1 Excludes
    • drug or chemical induced diabetes mellitus (E09.-)
    • gestational diabetes (O24.4-)
    • neonatal diabetes mellitus (P70.2)
    • postpancreatectomy diabetes mellitus (E13.-)
    • postprocedural diabetes mellitus (E13.-)
    • secondary diabetes mellitus NEC (E13.-)
    • type 1 diabetes mellitus (E10.-)
    • type 2 diabetes mellitus (E11.-)
    Use Additional
    • code to identify control using:
    • insulin (Z79.4)
    • oral antidiabetic drugs (Z79.84)
    • oral hypoglycemic drugs (Z79.84)
    ICD-10-CM Diagnosis Code E11

    Type 2 diabetes mellitus

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Includes
    • diabetes (mellitus) due to insulin secretory defect
    • diabetes NOS
    • insulin resistant diabetes (mellitus)
    Type 1 Excludes
    • diabetes mellitus due to underlying condition (E08.-)
    • drug or chemical induced diabetes mellitus (E09.-)
    • gestational diabetes (O24.4-)
    • neonatal diabetes mellitus (P70.2)
    • postpancreatectomy diabetes mellitus (E13.-)
    • postprocedural diabetes mellitus (E13.-)
    • secondary diabetes mellitus NEC (E13.-)
    • type 1 diabetes mellitus (E10.-)
    Use Additional
    • code to identify control using:
    • insulin (Z79.4)
    • oral antidiabetic drugs (Z79.84)
    • oral hypoglycemic drugs (Z79.84)
    ICD-10-CM Diagnosis Code E11

    Type 2 diabetes mellitus

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Includes
    • diabetes (mellitus) due to insulin secretory defect
    • diabetes NOS
    • insulin resistant diabetes (mellitus)
    Type 1 Excludes
    • diabetes mellitus due to underlying condition (E08.-)
    • drug or chemical induced diabetes mellitus (E09.-)
    • gestational diabetes (O24.4-)
    • neonatal diabetes mellitus (P70.2)
    • postpancreatectomy diabetes mellitus (E13.-)
    • postprocedural diabetes mellitus (E13.-)
    • secondary diabetes mellitus NEC (E13.-)
    • type 1 diabetes mellitus (E10.-)
    Use Additional
    • code to identify control using:
    • insulin (Z79.4)
    • oral antidiabetic drugs (Z79.84)
    • oral hypoglycemic drugs (Z79.84)
    ICD-10-CM Diagnosis Code E13

    Other specified diabetes mellitus

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Includes
    • diabetes mellitus due to genetic defects of beta-cell function
    • diabetes mellitus due to genetic defects in insulin action
    • postpancreatectomy diabetes mellitus
    • postprocedural diabetes mellitus
    • secondary diabetes mellitus NEC
    Type 1 Excludes
    • diabetes (mellitus) due to autoimmune process (E10.-)
    • diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-)
    • diabetes mellitus due to underlying condition (E08.-)
    • drug or chemical induced diabetes mellitus (E09.-)
    • gestational diabetes (O24.4-)
    • neonatal diabetes mellitus (P70.2)
    • type 1 diabetes mellitus (E10.-)
    Use Additional
    • code to identify control using:
    • insulin (Z79.4)
    • oral antidiabetic drugs (Z79.84)
    • oral hypoglycemic drugs (Z79.84)
    ICD-10-CM Diagnosis Code E13

    Other specified diabetes mellitus

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Includes
    • diabetes mellitus due to genetic defects of beta-cell function
    • diabetes mellitus due to genetic defects in insulin action
    • postpancreatectomy diabetes mellitus
    • postprocedural diabetes mellitus
    • secondary diabetes mellitus NEC
    Type 1 Excludes
    • diabetes (mellitus) due to autoimmune process (E10.-)
    • diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-)
    • diabetes mellitus due to underlying condition (E08.-)
    • drug or chemical induced diabetes mellitus (E09.-)
    • gestational diabetes (O24.4-)
    • neonatal diabetes mellitus (P70.2)
    • type 1 diabetes mellitus (E10.-)
    Use Additional
    • code to identify control using:
    • insulin (Z79.4)
    • oral antidiabetic drugs (Z79.84)
    • oral hypoglycemic drugs (Z79.84)

Diagnosis Index entries containing back-references to Z79.84:
  • Long-term (current) (prophylactic) drug therapy (use of)
    • oral
      • antidiabetic Z79.84
      • hypoglycemic Z79.84

ICD-10-CM Codes Adjacent To Z79.84
Z79.634 Long term (current) use of topoisomerase inhibitor
Z79.64 Long term (current) use of myelosuppressive agent
Z79.69 Long term (current) use of other immunomodulators and immunosuppressants
Z79.8 Other long term (current) drug therapy
Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels
Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
Z79.811 Long term (current) use of aromatase inhibitors
Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
Z79.82 Long term (current) use of aspirin
Z79.83 Long term (current) use of bisphosphonates
Z79.84 Long term (current) use of oral hypoglycemic drugs
Z79.85 Long-term (current) use of injectable non-insulin antidiabetic drugs
Z79.89 Other long term (current) drug therapy
Z79.890 Hormone replacement therapy
Z79.891 Long term (current) use of opiate analgesic
Z79.899 Other long term (current) drug therapy
Z80 Family history of primary malignant neoplasm
Z80.0 Family history of malignant neoplasm of digestive organs
Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung
Z80.2 Family history of malignant neoplasm of other respiratory and intrathoracic organs
Z80.3 Family history of malignant neoplasm of breast

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.